TITLE

Sulkowski (J Infect Dis 2013; 207(suppl 1):S26–32)

PUB. DATE
June 2013
SOURCE
Journal of Infectious Diseases;Jun2013, Vol. 207 Issue 12, p1940
SOURCE TYPE
Academic Journal
DOC. TYPE
Correction notice
ABSTRACT
A correction to the article "Current Management of Hepatitis C Virus Infection in Patients With HIV Co-infection," by Sulkowski in June 2013 issues is presented.
ACCESSION #
87826571

 

Related Articles

  • Influence of CD4 Cell Counts on the Genetic Heterogeneity of Hepatitis C Virus in Patients Coinfected with Human Immunodeficiency Virus. Roque-Alfonso, Anne Marie; Robain, Mathieu; Simoneau, Danielle; Rodriguez-Mathieu, Patricia; Gigou, Michèle; Meyer, Laurence; Dussaix, Elisabeth // Journal of Infectious Diseases;3/15/2002, Vol. 185 Issue 6, p728 

    To study the effects of reduced CD4 T cell activity on hepatitis C virus (HCV) genetic heterogeneity, HCV quasi-species complexity and diversification over time were analyzed for 56 human immunodeficiency virus-coinfected patients. Patients were selected retrospectively from the French...

  • Human Immunodeficiency Virus and Hepatitis C Virus: Which Is the Cart, and Which Is the Horse? Girón-González, José A.; Martinez-Sierra, Carmen; Arizcorreta, Ana; Díaz, Fernando // Clinical Infectious Diseases;9/1/2003, Vol. 37 Issue 5, p740 

    Informs about the evolution of liver disease in HIV-infected patients is influenced by the baseline CD4 cell count and the hepatitis C virus load. Relationship between the increase in CD4 cell count and the severity of the liver disease; Information about a study on the topic.

  • Prevalence and Characteristics of Hepatitis C Virus Coinfection in a Human Immunodeficiency Virus Clinical Trials Group: The Terry Beirn Community Programs for Clinical Research on AIDS. Tedaldi, Ellen M.; Hullsiek, Katherine Hoppler; Malvestutto, Carlos D.; Arduino, Roberto C.; Fisher, Evelyn J.; Gaglio, Paul J.; Jenny-Avital, Elizabeth R.; McGowan, Joseph P.; Perez, George // Clinical Infectious Diseases;5/15/2003, Vol. 36 Issue 10, p1313 

    The baseline prevalence of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection among 2705 patients enrolled in HIV clinical trials in the Community Programs for Clinical Research on AIDS (CPCRA) was 16.6%. For men, multivariate logistic regression showed that the baseline...

  • Table of Contents.  // Clinical Infectious Diseases;Dec2014, Vol. 59 Issue 12, pNP 

    A table of the contents for December 15, 2014 issue is presented.

  • Transmission of HCV NS5A Inhibitor–Resistant Variants Among HIV-Infected Men Who Have Sex With Men. Abravanel, Florence; Métivier, Sophie; Chauveau, Marie; Péron, Jean-Marie; Izopet, Jacques // Clinical Infectious Diseases;11/1/2016, Vol. 63 Issue 9, p1271 

    A letter to the editor is presented in response to the article about hepatitis C virus drug resistance associated HIV infection in men in the previous issue.

  • Evolution of Coinfection with Human Immunodeficiency Virus and Hepatitis C Virus in Patients Treated with Highly Active Antiretroviral Therapy. Torre, D.; Tambini, R.; Cadario, F.; Barbarini, G.; Moroni, M.; Basilico, C. // Clinical Infectious Diseases;11/1/2001, Vol. 33 Issue 9, p1579 

    Focuses on a study which examined patients coinfected with HIV and hepatitis C virus (HCV) who were treated with highly active antiretroviral therapy in Italy. Characteristics of the study population; Survival rate of patients coinfected with HIV and HCV; Evolution of HCV genotypes and disease.

  • Prevalence of HCV, HBV and HIV infections in patients and staff of haemodialysis unit. Palanisamy, Saraswathy; Patil, Santhosh B.; Baskaran, K.; Narayana, H. Shankar // BMC Infectious Diseases;2012 Supplement, Vol. 12 Issue Supplment 1, p1 

    The article presents a study which investigates the prevalence of hepatitis C virus (HCV), hepatitis B virus (HBV) and HIV infections in hemodialysis (HD) patients and staff of haemodialysis unit. The cross sectional study tested serum samples from 60 end stage renal disease (ESRD) patients who...

  • Lopinavir/ritonavir pharmacokinetics in HIV and hepatitis C virus co-infected patients without liver function impairment: influence of liver fibrosis. Moltó, José; Valle, Marta; Blanco, Asunción; Negredo, Eugenia; DelaVarga, Meritxell; Miranda, Cristina; Miranda, José; Domingo, Pere; Vilaró, Josep; Tural, Cristina; Costa, Joan; Barbanoj, Manuel José; Clotet, Bonaventura; Moltó, José; Blanco, Asunción; Miranda, José; Vilaró, Josep; Barbanoj, Manuel José // Clinical Pharmacokinetics;2007, Vol. 46 Issue 1, p85 

    BACKGROUND AND OBJECTIVE: To assess the influence of hepatitis C virus (HCV) co-infection and the extent of liver fibrosis on lopinavir/ritonavir pharmacokinetics in HIV-infected patients without liver function impairment. METHODS: Cross-sectional, comparative study enrolling HIV-infected...

  • Solitary Polypoid Laryngeal Xanthoma. Vera-Sempere, Francisco; Collado-Martín, Diego; Vera-Sirera, Beatriz // Case Reports in Otolaryngology;2013, p1 

    We report the case of a 51-year-old male smoker with diabetes mellitus and hyperlipidaemia and a long history of human immunodeficiency virus (HIV)/hepatitis C virus (HCV) infection treated with various antiretroviral regimes, who was referred to the otolaryngology department with progressive...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics